Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  Danaher    DHR

DANAHER (DHR)
Mes dernières consult.
Most popular
Report
Delayed Quote. Delayed  - 12/11 10:02:23 pm
93.21 USD   +0.03%
12/05 DANAHER : Announces Quarterly Dividend
11/28 DANAHER : Announces Leadership Appointment
11/27 DANAHER : Beckman Coulter Enters Commercial Dispute with Quidel to S..
 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nyse
12/05/2017 12/06/2017 12/07/2017 12/08/2017 12/11/2017 Date
92.74(c) 92.53(c) 92.68(c) 93.18(c) 93.21(c) Last
2 376 939 2 038 382 1 787 794 1 538 112 1 802 908 Volume
-0.09% -0.23% +0.16% +0.54% +0.03% Change
More quotes
Financials ($)
Sales 2017 18 192 M
EBIT 2017 3 420 M
Net income 2017 2 303 M
Debt 2017 9 325 M
Yield 2017 0,57%
Sales 2018 19 009 M
EBIT 2018 3 678 M
Net income 2018 2 625 M
Debt 2018 6 168 M
Yield 2018 0,60%
P/E ratio 2017 29,73
P/E ratio 2018 27,08
EV / Sales2017 4,08x
EV / Sales2018 3,73x
Capitalization 64 816 M
More Financials
Company
Danaher Corp. operates as a medical company, which designs, manufactures, and markets healthcare, environmental, and industrial equipment.It operates through the following segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.The Life Sciences segment offers a range of... 
More about the company
Surperformance© ratings of Danaher
Trading Rating : Investor Rating :
More Ratings
Latest news on DANAHER
12/05 DANAHER : Announces Quarterly Dividend
11/28 DANAHER : Announces Leadership Appointment
11/27 DANAHER : Beckman Coulter Enters Commercial Dispute with Quidel to Sell BNP Dire..
11/14 DANAHER : to Webcast Investor and Analyst Meeting
11/13 SONOVA : misses sales, profit forecasts as U.S. overhaul bites
11/01 DANAHER : to Present at Baird Industrial Conference
10/31 DANAHER : IDBS and Danaher accelerate innovation in drug development
10/25 DANAHER : Earnings Review and Free Research Report: Danaher’s EPS Increased 13.9..
10/19 S&P 500 MOVERS : Gpc, adbe
10/19 DANAHER : tops Street 3Q forecasts
More news
Sector news : Advanced Medical Equipment & Technology - NEC
12/08DJROYAL PHILIPS : Philips Buys VitalHealth for Undisclosed Sum
12/08 SAFRA CATZ : Oracle's Safra Catz among two new members named to Disney board
12/05DJROYAL PHILIPS : Philips Buys Interoperability Provider Forcare for Undisclosed S..
11/29DJROYAL PHILIPS : Cuts Stake in Philips Lighting With EUR547 Million Share Sale
11/28 PHILIPS LIGHTING : cuts holding in Lighting with $600 mln share sale
More sector news : Advanced Medical Equipment & Technology - NEC
4-Traders Strategies on DANAHER 
DANAHER CORPORATION - 2012
Strong support to help a rebound
BUY
More Strategies
News from SeekingAlpha
12/05 Danaher Corporation declares $0.14 dividend
12/05 GenMark's Credibility Is Dented, But The Sell-Off Is Excessive
11/26 THE GOOD BUSINESS PORTFOLIO : 2017 3rd Quarter Earnings And Performance Review
11/25 Tracking Charles Akre's Akre Capital Management Portfolio - Q3 2017 Update
11/22 MAIN STREET CAPITAL : One Out Of Two
Chart DANAHER
Duration : Period :
Danaher Technical Analysis Chart | DHR | US2358511028 | 4-Traders
Technical analysis trends DANAHER
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 15
Average target price 96,5 $
Spread / Average Target 3,5%
EPS Revisions
Managers
NameTitle
Thomas Patrick Joyce President, Chief Executive Officer & Director
Stephen M. Rales Chairman
Daniel L. Comas Chief Financial Officer & Executive Vice President
Alan G. Spoon Independent Director
Donald Jerry Ehrlich Lead Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
DANAHER19.14%64 816
THERMO FISHER SCIENTIFIC INC.29.31%74 976
INTUITIVE SURGICAL74.80%42 534
ROYAL PHILIPS11.71%36 093
BOSTON SCIENTIFIC CORPORATION15.30%35 387
ILLUMINA64.84%31 777